Point72 (DIFC)’s Nuvalent NUVL Stock Holding History

Point72 (DIFC)’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,355	Closed	-$928K	–	1775
2024 Q1	$928K	Buy	+12,355	New	+$983K	0.03%	587

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 (DIFC)'s NUVL Position: Q2 2024 in Review

Point72 (DIFC) sold out of Nuvalent (NUVL) in Q2 2024, closing a stake of 12,355 shares — an estimated $928K sold.

Point72 (DIFC) first reported a position in NUVL in Q1 2024 and held it in 1 quarter. The position peaked at $928K in Q1 2024. 172 funds tracked by Wall St. Rank hold NUVL as of Q2 2024.

Point72 (DIFC) reported no remaining Nuvalent position as of Q2 2024 after selling out during the quarter.
Point72 (DIFC) sold 12,355 Nuvalent shares in Q2 2024, an estimated $928K.
Point72 (DIFC) first reported a position in Nuvalent in Q1 2024 and held it in 1 quarter.
Point72 (DIFC)'s Nuvalent position peaked at $928K in Q1 2024.
172 funds tracked by Wall St. Rank held Nuvalent as of Q2 2024.

Based on Point72 (DIFC)'s 13F filing for Q2 2024, filed 14 Aug 2024.